Onyx Seeks Suitors After Rejecting Amgen’s Bid

July 1 (Bloomberg) -- Onyx Pharmaceuticals, the maker of the cancer drug Nexavar, said it is in contact with other possible acquirers after rejecting an unsolicited $120-a-share cash takeover bid from Amgen Onyx shares surged. Dominic Chu reports on Bloomberg Television's "Market Makers." (Source: Bloomberg)
Google Picks 20 Finalists for Annual Science Fair
44:43 - Today’s "BWest Byte" is 20, for the number of students between the ages of 13 and 18 who were selected as finalists for the fifth annual Google Science Fair. Bloomberg's Emily Chang reports on "Bloomberg West." (Source: Bloomberg)
  • Why Homes Are Becoming Harder to Find
  • Redfin's CEO: Here's What Keeps Me Up at Night
  • Disney's 3rd-Qtr Earnings Beat: Breaking Down the Numbers